Cargando…
EPPIC (Efficient Purification by Parental Inducer Constraint) Platform for Rapid Generation of Recombinant Vaccinia Viruses
Vaccinia virus (VACV) was successfully used as a vaccine in the smallpox eradication campaign. Since then, it has been widely used in the development of vaccine and therapeutic vectors. However, methods of generating and purifying recombinant VACVs (rVACVs) are often time-consuming, cumbersome, and...
Autores principales: | Jasperse, Brittany, O’Connell, Caitlin M., Wang, Yuxiang, Verardi, Paulo H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7177189/ https://www.ncbi.nlm.nih.gov/pubmed/32346550 http://dx.doi.org/10.1016/j.omtm.2020.03.026 |
Ejemplares similares
-
Single dose of a replication-defective vaccinia virus expressing Zika virus-like particles is protective in mice
por: Jasperse, Brittany, et al.
Publicado: (2021) -
Replication-inducible vaccinia virus vectors with enhanced safety in vivo
por: O’Connell, Caitlin M., et al.
Publicado: (2020) -
Generation of Multiple Arbovirus-like Particles Using a Rapid Recombinant Vaccinia Virus Expression Platform
por: Wang, Yuxiang, et al.
Publicado: (2022) -
Risk factors for progression of chronic kidney disease in the EPPIC trials and the effect of AST-120
por: Schulman, Gerald, et al.
Publicado: (2017) -
A vaccinia virus renaissance: New vaccine and immunotherapeutic uses after smallpox eradication
por: Verardi, Paulo H., et al.
Publicado: (2012)